Page last updated: 2024-10-20

pyridoxal phosphate and Carcinoma, Hepatocellular

pyridoxal phosphate has been researched along with Carcinoma, Hepatocellular in 40 studies

Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research Excerpts

ExcerptRelevanceReference
"The purpose of this study was to study the effects of serum folate and plasma pyridoxal 5'-phosphate (PLP) on plasma homocysteine, oxidative stress and antioxidant capacities in 44 hepatocellular carcinoma (HCC) patients and 56 healthy controls."7.83Folate and vitamin B-6 status are not associated with homocysteine, oxidative stress and antioxidant capacities in patients with hepatocellular carcinoma. ( Cheng, SB; Huang, YC; Lai, CY; Lin, PT; Liu, HT, 2016)
"To determine the efficacy of manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate) (DPDP) at magnetic resonance (MR) imaging for evaluation of hepatocellular carcinoma (HCC)."5.08Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). ( Baron, RL; Confer, SR; Davis, PL; Federle, MP; Murakami, T; Oliver, JH; Peterson, MS, 1996)
"The purpose of this study was to study the effects of serum folate and plasma pyridoxal 5'-phosphate (PLP) on plasma homocysteine, oxidative stress and antioxidant capacities in 44 hepatocellular carcinoma (HCC) patients and 56 healthy controls."3.83Folate and vitamin B-6 status are not associated with homocysteine, oxidative stress and antioxidant capacities in patients with hepatocellular carcinoma. ( Cheng, SB; Huang, YC; Lai, CY; Lin, PT; Liu, HT, 2016)
"Rats fed diets deficient in choline develop hepatocellular carcinoma."3.79Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma. ( Arning, E; Bottiglieri, T; Butler, LM; Gao, YT; Govindarajan, S; Wang, R; Yuan, JM, 2013)
"Twenty-one patients with 39 hepatocellular carcinomas underwent ferumoxides-enhanced and mangafodipir trisodium-enhanced MR imaging."2.70Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging. ( Choi, D; Kim, H; Kim, SH; Kim, SK; Lee, SJ; Lee, WJ; Lim, HK; Lim, JH; Seo, JW, 2002)
"Fifty patients with liver cirrhosis and histologically proven HCC were enrolled in a prospective phase-IIIB clinical trial."2.69MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. ( Bartolozzi, C; Cioni, D; Crocetti, L; Donati, F; Lencioni, R, 2000)
"Intrahepatic thrombus is usually associated with either cirrhosis or hepatocellular carcinoma (HCC)."2.68Tumoural portal vein thrombosis. Enhancement with MnDPDP. ( Anglade, MC; Coffin, C; Lonjedo, E; Marti-Bonmati, L; Mathieu, D; Poyatos, C, 1997)
"We used cultured human hepatoma cells and evaluated static intracellular profiles of amino acids and in vivo kinetics of H2S biomarker formation."1.40Vitamin B-6 restriction reduces the production of hydrogen sulfide and its biomarkers by the transsulfuration pathway in cultured human hepatoma cells. ( Banerjee, R; Chi, YY; DeRatt, BN; Gregory, JF; Kabil, O; Ralat, MA, 2014)
"Hypotonicity triggered in human hepatoma cells (Huh-7) the release of ATP and cell swelling, followed by volume regulatory decrease (RVD)."1.39On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cells. ( Alberti, GS; Alvarez, CL; Davio, C; de Tezanos Pinto, F; Espelt, MV; Incicco, J; Leal Denis, MF; Schwarzbaum, PJ, 2013)
"The lesions in hepatocellular carcinomas patients showed a non-homogeneous enhancement pattern."1.33Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. ( Adigüzel, Y; Haykir, R; Karabacakoğlu, A; Karaköse, S; Kayaçetin, E, 2006)
"Forty-six patients with 96 hepatocellular carcinomas underwent Mn-DPDP- and gadopentetate dimeglumine-enhanced MRI."1.32MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents. ( Kim, CS; Lee, JM; Youk, JH, 2004)
"These two cases had hepatocellular carcinoma and fibrolamellar hepatocellular carcinoma, respectively, confirmed on liver biopsy."1.31Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma. ( Burkill, GJ; Healy, JC; Mannion, EM, 2001)
"A total of 69 primary and secondary liver cancers from these three animal models were studied."1.29Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study. ( Baert, AL; Lodemann, KP; Marchal, G; Ni, Y; Rummeny, E; Yu, J; Zhang, X, 1993)

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19909 (22.50)18.7374
1990's11 (27.50)18.2507
2000's15 (37.50)29.6817
2010's5 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Espelt, MV1
de Tezanos Pinto, F1
Alvarez, CL1
Alberti, GS1
Incicco, J1
Leal Denis, MF1
Davio, C1
Schwarzbaum, PJ1
Butler, LM1
Arning, E1
Wang, R1
Bottiglieri, T1
Govindarajan, S1
Gao, YT1
Yuan, JM1
DeRatt, BN1
Ralat, MA2
Kabil, O1
Chi, YY1
Banerjee, R1
Gregory, JF2
Cheng, SB1
Liu, HT1
Lin, PT1
Lai, CY1
Huang, YC1
Kim, JH1
Kim, MJ2
Park, YN1
Lee, JT1
Kim, BR1
Chung, JB1
Choi, JS1
Kim, KS1
Kim, KW2
Zhao, M1
da Silva, V1
Garrett, TJ1
Melnyk, S1
James, SJ1
Kim, SK1
Kim, SH1
Lee, WJ1
Kim, H1
Seo, JW1
Choi, D1
Lim, HK1
Lee, SJ1
Lim, JH1
Wang, DB1
Zhou, KR1
Zeng, MS1
Chen, KM1
Wang, YX1
Guo, T1
Zhang, XL1
Chang, RM1
Zhang, YZ1
ITO, K2
NAKAHARA, I2
SAKAMOTO, Y2
Bedda, S1
Laurent, A1
Conti, F1
Chéreau, C1
Tran, A1
Tran-Van Nhieu, J1
Jaffray, P1
Soubrane, O1
Goulvestre, C1
Calmus, Y1
Weill, B1
Batteux, F1
Savellano, DH1
Köstler, H1
Baus, S1
Mössinger, M1
Gratz, KF1
Weimann, A1
Galanski, M1
Youk, JH1
Lee, JM1
Kim, CS1
Chung, JJ1
Karabacakoğlu, A1
Adigüzel, Y1
Karaköse, S1
Kayaçetin, E1
Haykir, R1
Liou, J1
Lee, JK2
Borrello, JA1
Brown, JJ1
Ni, Y1
Marchal, G1
Yu, J1
Rummeny, E2
Zhang, X1
Lodemann, KP1
Baert, AL1
Rofsky, NM1
Weinreb, JC1
Bernardino, ME1
Young, SW1
Noz, ME1
Murakami, T1
Baron, RL1
Peterson, MS1
Oliver, JH1
Davis, PL1
Confer, SR1
Federle, MP1
Chezmar, JL1
Redvanly, RD1
Sewell, CW1
Padovani, B1
Lecesne, R1
Raffaelli, C1
Chevallier, P1
Drouillard, J1
Bruneton, JN1
Lambrechts, M1
Gordon, P1
Kettritz, U1
Schlund, JF1
Wilbur, K1
Eisenberg, LB1
Semelka, RC1
Marti-Bonmati, L1
Lonjedo, E1
Mathieu, D2
Coffin, C1
Poyatos, C1
Anglade, MC1
Wang, C1
Coffin, CM1
Diche, T1
Mahfouz, A1
Alexandre, M1
Caseiro-Alves, F1
Rahmouni, A1
Vasile, N1
Bartolozzi, C1
Donati, F1
Cioni, D1
Crocetti, L1
Lencioni, R1
Burkill, GJ1
Mannion, EM1
Healy, JC1
Grimm, J1
Müller-Hülsbeck, S1
Blume, J1
Biederer, J1
Heller, M1
Iciek, MB1
Rokita, HB1
Wlodek, LB1
Helmberger, TK1
Laubenberger, J1
Jung, G1
Sievers, K1
Döhring, W1
Meurer, K1
Reiser, MF1
Seltzer, SE1
Getty, DJ1
Pickett, RM1
Swets, JA1
Sica, G1
Brown, J1
Saini, S1
Mattrey, RF1
Harmon, B1
Francis, IR1
Chezmar, J1
Schnall, MO1
Siegelman, ES1
Ballerini, R1
Bhat, S1
Hamm, B1
Vogl, TJ1
Branding, G1
Schnell, B1
Taupitz, M1
Wolf, KJ1
Lissner, J1
Zaman, SN1
Tredger, JM1
Johnson, PJ1
Williams, R1
Herzfeld, A1
Knox, WE1
Bukin, IuV1
Sergeev, AV1
Raushenbakh, MO1
Hosoda, S1
Nakamura, W1
Snell, KC1
Stewart, HL1
Grigo, KM1
Von Redlich, D1
Glick, D1
Goriukhina, TA1
Lebedeva, SB1
Harik, SI1
Hollenberg, MD1
Snyder, SH1

Trials

13 trials available for pyridoxal phosphate and Carcinoma, Hepatocellular

ArticleYear
Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging.
    AJR. American journal of roentgenology, 2002, Volume: 179, Issue:3

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Dextrans; Edetic Acid; False Negative Reacti

2002
Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Journal of magnetic resonance imaging : JMRI, 2006, Volume: 23, Issue:5

    Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarc

2006
Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
    Radiology, 1993, Volume: 188, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential;

1993
Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Radiology, 1996, Volume: 200, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Confidence Intervals; Contrast Media; Ede

1996
Uptake of mangafodipir trisodium (MnDPDP) by hepatocellular carcinoma: correlation with unenhanced imaging findings and histopathologic features.
    Academic radiology, 1996, Volume: 3 Suppl 2

    Topics: Adult; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Image Enhancement; Li

1996
Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
    European journal of radiology, 1996, Volume: 23, Issue:3

    Topics: Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Infusions, Intravenous; Live

1996
Tumoural portal vein thrombosis. Enhancement with MnDPDP.
    Acta radiologica (Stockholm, Sweden : 1987), 1997, Volume: 38, Issue:4 Pt 2

    Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Liv

1997
Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging.
    European radiology, 1999, Volume: 9, Issue:3

    Topics: Adenoma, Liver Cell; Adult; Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Contrast Media; Diagnos

1999
MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis.
    European radiology, 2000, Volume: 10, Issue:11

    Topics: Carcinoma, Hepatocellular; Edetic Acid; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Cirrho

2000
[Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2001, Volume: 173, Issue:3

    Topics: Adenoma; Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cysts; Diagnosis, Diffe

2001
MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool.
    European radiology, 2002, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Contrast

2002
Multimodality diagnosis of liver tumors: feature analysis with CT, liver-specific and contrast-enhanced MR, and a computer model.
    Academic radiology, 2002, Volume: 9, Issue:3

    Topics: Adult; Carcinoma, Hepatocellular; Computer Simulation; Contrast Media; Edetic Acid; Humans; Liver Ne

2002
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
    Radiology, 1992, Volume: 182, Issue:1

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Fe

1992

Other Studies

27 other studies available for pyridoxal phosphate and Carcinoma, Hepatocellular

ArticleYear
On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cells.
    American journal of physiology. Cell physiology, 2013, May-15, Volume: 304, Issue:10

    Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Azo Compounds; Brefeldin A

2013
Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013, Volume: 22, Issue:10

    Topics: Aged; Animals; Carcinoma, Hepatocellular; Case-Control Studies; Choline; Cohort Studies; Humans; Liv

2013
Vitamin B-6 restriction reduces the production of hydrogen sulfide and its biomarkers by the transsulfuration pathway in cultured human hepatoma cells.
    The Journal of nutrition, 2014, Volume: 144, Issue:10

    Topics: Alanine; Biomarkers; Carcinoma, Hepatocellular; Cysteine; Hep G2 Cells; Homocysteine; Humans; Hydrog

2014
Folate and vitamin B-6 status are not associated with homocysteine, oxidative stress and antioxidant capacities in patients with hepatocellular carcinoma.
    European journal of clinical nutrition, 2016, Volume: 70, Issue:7

    Topics: Aged; Antioxidants; Carcinoma, Hepatocellular; Female; Folic Acid; Glutathione Peroxidase; Glutathio

2016
Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics.
    Clinical radiology, 2008, Volume: 63, Issue:11

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Cell Differentiation; Contrast Media; Edetic Acid; Female; H

2008
Vitamin B-6 restriction impairs fatty acid synthesis in cultured human hepatoma (HepG2) cells.
    American journal of physiology. Endocrinology and metabolism, 2013, Feb-15, Volume: 304, Issue:4

    Topics: Carcinoma, Hepatocellular; Cell Membrane; Delta-5 Fatty Acid Desaturase; Down-Regulation; Fatty Acid

2013
Mn-DPDP-enhanced 24-h delayed-scan MRI of hepatocellular carcinoma is correlated with histology.
    European radiology, 2004, Volume: 14, Issue:4

    Topics: Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Res

2004
[Comparative study of four GRE sequences in MnDPDP-enhanced magnetic resonance imaging for primary hepatocellular carcinoma].
    Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2003, Volume: 23, Issue:9

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Image Enhanceme

2003
[STUDIES ON VITAMIN B6 METABOLISM OF CANCER CELLS AND TUMOR-BEARING RAT LIVER. I. ENZYME ACTIVITIES RELATED TO VITAMIN B6 METABOLISM].
    Gan, 1964, Volume: 55

    Topics: Carcinoma, Hepatocellular; Flavin Mononucleotide; Liver; Liver Neoplasms; Metabolism; Neoplasms, Exp

1964
[STUDIES ON VITAMIN B6 METABOLISM OF CANCER CELLS AND TUMOR-BEARING RAT LIVER. II. UPTAKE OF PYRIDOXINE DERIVATIVES BY TUMOR CELLS AND THE LIVER OF TUMOR-BEARING RATS].
    Gan, 1964, Volume: 55

    Topics: Carcinoma, Hepatocellular; Liver; Liver Neoplasms; Neoplasms; Neoplasms, Experimental; Permeability;

1964
Mangafodipir prevents liver injury induced by acetaminophen in the mouse.
    Journal of hepatology, 2003, Volume: 39, Issue:5

    Topics: Acetaminophen; Animals; Antibodies, Monoclonal; Antioxidants; Carcinoma, Hepatocellular; Caspase 3;

2003
Assessment of sequential enhancement patterns of focal nodular hyperplasia and hepatocellular carcinoma on mangafodipir trisodium enhanced MR imaging.
    Investigative radiology, 2004, Volume: 39, Issue:5

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Focal Nodular Hyperplas

2004
MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
    AJR. American journal of roentgenology, 2004, Volume: 183, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential;

2004
Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2006, Volume: 17, Issue:3

    Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarc

2006
Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images.
    Magnetic resonance imaging, 1994, Volume: 12, Issue:1

    Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Hemangioma, Caverno

1994
Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study.
    Radiology, 1993, Volume: 188, Issue:1

    Topics: Angiography; Animals; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Liver Neoplasms; Liver

1993
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
    Magnetic resonance imaging, 1996, Volume: 14, Issue:10

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gado

1996
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Acta radiologica. Supplementum, 1998, Volume: 415

    Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Bar

1998
Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma.
    Clinical radiology, 2001, Volume: 56, Issue:1

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Liver Neoplasms; Lympha

2001
Effects of diallyl disulfide and other donors of sulfane sulfur on the proliferation of human hepatoma cell line (HepG2).
    Neoplasma, 2001, Volume: 48, Issue:4

    Topics: Allyl Compounds; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Cystamine; Disulfi

2001
Vitamin B6 concentrations in patients with chronic liver disease and hepatocellular carcinoma.
    British medical journal (Clinical research ed.), 1986, Jul-19, Volume: 293, Issue:6540

    Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Humans; Liver Diseases; Liver Neoplasms; Middle

1986
The properties, developmental formation, and estrogen induction of ornithine aminotransferase in rat tissues.
    The Journal of biological chemistry, 1968, Jun-25, Volume: 243, Issue:12

    Topics: Animals; Carcinoma, Hepatocellular; Castration; Enzyme Induction; Estradiol; Female; Fetus; Intestin

1968
[New route of regulating folic acid metabolism in experimental chemotherapy of leukoses and malignant neoplasms].
    Vestnik Akademii meditsinskikh nauk SSSR, 1971, Volume: 26, Issue:3

    Topics: Animals; Carcinoma, Hepatocellular; Cycloserine; Female; Folic Acid; Leukemia, Experimental; Liver;

1971
Histidine decarboxylase in the transplantable argyrophilic gastric carcinoid of Praomys (Mastomys) natalensis.
    Biochemical pharmacology, 1971, Volume: 20, Issue:10

    Topics: Ammonium Sulfate; Animals; Carboxy-Lyases; Carcinoid Tumor; Carcinoma, Ehrlich Tumor; Carcinoma, Hep

1971
Fluorometric determination of pyridoxal phosphate in microgram samples of tissue.
    Analytical biochemistry, 1972, Volume: 50, Issue:1

    Topics: Adrenal Glands; Animals; Carcinoid Tumor; Carcinoma, Hepatocellular; Cattle; Cyanides; Evaluation St

1972
[Isoenzyme spectrum of serine transoxymethylase in the liver and in hepatomas].
    Voprosy onkologii, 1973, Volume: 19, Issue:5

    Topics: Agar; Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Electrophoresis; Gels; Glycine; Isoenzyme

1973
Ornithine decarboxylase turnover slowed by alpha-hydrazino-ornithine.
    Molecular pharmacology, 1974, Volume: 10, Issue:1

    Topics: Animals; Brain; Carbon Radioisotopes; Carboxy-Lyases; Carcinoma, Hepatocellular; Cycloheximide; Dith

1974